Historical review from 2026-11-20. Current price and availability are unconfirmed; check the original marketplace.
Omnira generates $19.5K/mo with exceptional 65% profit margins and trades at a 2.7x annual profit multiple—well below typical SaaS multiples and attractive for a consumer app with verified profitability. The 8D Audio Creator feature offers meaningful product differentiation in the competitive wellness category. Buyer should confirm active user count, monthly/annual churn, and the breakdown of revenue streams (IAP, subscriptions, etc.) to validate recurring-revenue durability and unit economics.
The core software—iOS app with audio processing, IAP/subscription infrastructure, and user authentication—is reproducible with AI-assisted development in 14–18 weeks and $15K–$35K in hard costs (Claude Pro + Supabase + audio libraries). However, Omnira's value lies primarily in its verified $12.7K/mo profit, 65% margins, and established iOS distribution footprint, not the code itself. The 8D Audio Creator feature requires audio-engineering expertise and proprietary tuning; rebuilding equivalent differentiation would require additional research and iteration. Buying preserves proven revenue, paying users, and operating knowledge; building demands customer acquisition and product-market validation from scratch. At 2.7x multiple on verified profit, acquisition is preferable to bootstrapping a competing wellness app.
Cash estimate includes the AI tools, APIs and infrastructure needed for a solo founder to recreate the software. Build time is informational and lightly weighted. The verdict is driven mainly by customers, users, verified earnings, retention, distribution, brand, data and operating history.
Omnira is a profitable iOS wellness app for sleep, focus, and relaxation. Its standout 8D Audio Creator transforms music into an immersive listening experience. Users can also create personalized medi
Opens the original listing on TrustMRR
Get new listings with asking prices, monthly profit, deal scores, and key risks.
The best reviewed deals, concise and evidence-first. Unsubscribe anytime.
Preliminary screening based on marketplace and public data. Verify all financial, legal, technical, customer, and operational claims independently before making an acquisition decision. This is not financial or legal advice.